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Abstract Objective To compare the therapeutic efficacy of cimetidine and cryotherapy versus placebo and 
cryotherapy for treatment of warts. 
 
Methods This randomized, double-blind clinical trial was conducted on subjects with warts between 
2008 and 2009. Exclusion criteria of this study were Raynaud’s phenomenon, peripheral vascular 
disease, previous wart treatment and cold urticaria. Subjects were randomly allocated in two groups. 
In the first group cimetidine was administered, 40 mg/kg daily for three months, also, their warts 
were frozen monthly for three months. In the second group placebo was administered and their 
warts were frozen monthly for three month. Recurrence and cure rates for each group were recorded 
and data were statically analyzed. 
 
Results 81 subjects were recruited in this study. The mean cure rate obtained one month after 
treatment was 77.6% in cimetidine-treated group versus 79.3% in placebo-treated group, and the 
mean cure rate two month after treatment was 93.2% in cimetidine-treated group and 94.6% in 
placebo-treated group. The mean recurrence rate one month after treatment was 16% in cimetidine-
treated group and 15.5% in placebo-treated group, the mean recurrence rate two month after 
treatment was 22.3% in cimetidine-treated group and 23.3% in placebo-treated group, the mean 
recurrence rate three month after treatment was 31.7% in cimetidine-treated group and 30.1% in 
placebo-treated group. 
 
Conclusion This study showed that cimetidine is not more effective than placebo in treatment of 
warts. 
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Introduction 
A wart is generally a small, rough growth, 
typically on a human’s hands or feet but often 
other locations, that can resemble a cauliflower 
or a solid blister. They are caused by a viral 
infection, specifically by one of the many types 
of human papillomavirus.1 There are as many as 
10 varieties of warts, the most common 
considered to be mostly harmless. It is possible 
to get warts from others; they are contagious and 
usually enter the body in an area of broken skin.2 
They typically disappear after a few months but 
can last for years and can recur. A range of types 
of warts have been identified, varying in shape 
and site affected, as well as the type of human 
papillomavirus involved. These include: 
common warts (verruca vulgaris), flat warts 
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(verruca plana), filiform or digitate warts, 
genital warts (venereal warts, condyloma 
acuminatum, verruca acuminata), mosaic warts, 
plantar warts, periungual warts, plantar warts 
(verruca plantaris).  
Warts are caused by the human papillomavirus 
(HPV). There are about 130 known types of 
human papilloma viruses.
5
 HPV infects the 
squamous epithelium, usually of the skin or 
genitals, but each HPV type is typically only 
able to infect a few specific areas on the body. 
Many HPV types can produce a benign growth, 
often called a "wart" or "papilloma", in the area 
they infect.  
Wart treatments require patience. How well wart 
treatments work is another matter. Warts can 
appear and disappear without an identifiable 
cause and may disappear on their own without 
treatment. Some warts sprout offshoots near the 
main wart, and others don't.. Some hurt, and 
others are painless. There are many treatments 
and procedures associated with wart removal 
like: salicylic acid, placebo, podophyllin resin 
paint, benzoin, aloes, isopropyl alcohol, 
imiquimod, dinitrochlorobenzene, bleomycin, 
cantharidin, cryosurgery or cryotherapy, 
electrodesiccation, medication, cimetidine. 
Methods 
This randomized, double-blind clinical trial was 
conducted on subjects with warts between 2008 
and 2009. Exclusion criteria of this study were 
Raynaud’s phenomenon, peripheral vascular 
disease, previous wart treatment and cold 
urticaria. Subjects were randomly allocated into 
two groups. In the first group, cimetidine was 
administered, 40 mg/kg daily for three months; 
also, their warts were frozen monthly for three 
months. In the second group placebo was 
administered and their warts were frozen 
monthly for three month. Cryotherapy was 
performed by liquid nitrogen spray for 5-10 
seconds for each lesion.  
Recurrence and cure rates for each subject were 
recorded monthly and data were statically 
analyzed. 
Results 
Total number of 81 subjects were recruited in 
this study, 41 in the cimetidine group and 40 in 
the placebo group (Table 1). The mean age in 
cimetidine-treated group was 19.2 and in 
placebo-treated group was 21.3 (p=0.24). In 
total, 34 patients were females (41.9%), and 47 
were males (58.1%). In cimetidine-treated 
group, 25 patients were males (60.9%) and 16 
patients were females (29.1%) and in placebo-
treated group 22 (55%) patients were males and 
18 (45%) patients were females (p=0.38).  
The mean number of warts in cimetidine-group 
was 20.8 and in placebo-treated group was 21 
(p=0.94). The kinds of lesions in two groups 
were similar (p=0.83). The mean size of lesions 
in cimetidine-treated group was 8.1mm and in 
placebo-treated group was 10mm (p=0.17).  The 
Table 1 Demographic and clinical profile of two 
groups. 
Parameter Cimetidine 
Group 
(n=41) 
Placebo 
Group 
(n=40) 
Mean age (years) 19.2 21.3 
Male 25 (60.9%) 22 (55%) 
Female 16 (29.1%) 18 (45%) 
Mean number of warts 20.8 21 
Mean size of lesions 8.1mm 10mm 
Mean duration  12 months 9 months 
Site of lesions   
Face 4 (9.8%) 5 (12.5%) 
Neck 4 (9.7%) 3 (7.5%) 
Face and neck 1 (2.4%) 2 (5%) 
Hands 19 (46.3%) 14 (35%) 
Feet 5 (12.2%) 7 (17.5%) 
Hands and feet 8 (19.5%) 9 (22.5%) 
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Table 2 Cure rate and relapse rate in the two 
treatment groups. 
 Cimetidine  
Group 
Placebo  
group 
Cure rate   
One month after 77.6% 79.3% 
Two months after 93.2% 94.6% 
Recurrence rate   
One month after 16% 15.5% 
Two months after 22.3% 23.3% 
Three months after 31.3% 30.1% 
mean duration of lesions in cimetidine-treated 
group was 12 months, and in placebo-treated 
group was 9 months (p=0.18).  
The mean cure rate obtained one month after 
treatment was 77.6% in cimetidine-treated group 
versus 79.3% in placebo-treated group (Table 
2), (p=0.53). After 2 months it rose to 93.2% in 
cimetidine-treated group and 94.6% in placebo-
treated group, (p= 0.61). 
The mean recurrence rate one month after 
treatment was 16% in cimetidine-treated group 
and in placebo-treated group was 15.5%, 
(p=0.92). The mean recurrence rate two month 
after treatment was 22.3% in cimetidine-treated 
group and 23.3% in placebo-treated group 
(p=0.83). Mean recurrence rate three month after 
treatment was 31.7% in cimetidine-treated group 
and 30.1% in placebo-treated group (p=0.76). 
Discussion 
Various type of treatment are available for 
warts.3 Recently cimetidine has been shown to 
be effective in treating warts but therapeutic 
results are controversial. Because of this 
controversy, we decided to compare the 
therapeutic efficacy of cimetidine and 
cryotherapy vs placebo and cryotherapy for 
treatment of warts. 
Total number of 81 subjects were recruited in 
this study. Subjects were randomly allocated in 
two groups. In the first group cimetidine was 
administered, 40 mg/kg daily for three months, 
also, their warts were frozen monthly for three 
months. In the second group placebo was 
administered and their warts were frozen 
monthly for three month. Recurrence and cure 
rates for each subject were recorded and data 
were statically analyzed. The two groups were 
well-matched in terms of age, number of warts 
and size of lesions  
The mean cure rate obtained one month after 
treatment was 77.6% in cimetidine-treated group 
and 79.3% in placebo-treated group and there 
was no any significant difference between two 
groups (p=0.53). The mean cure rate two month 
after treatment was 93.2% in cimetidine-treated 
group and 94.6% in placebo-treated group, and 
there was no any significant difference between 
two groups (p= 0.61).  
The mean recurrence rate one month after 
treatment was 16% in cimetidine-treated group, 
and in placebo-treated group was 15.5%, and 
there was no any significant difference between 
two groups (p=0.92). The recurrence rate was 
similar after two months i.e. 22.3% in 
cimetidine-treated group and 23.3% in placebo-
treated group (p=0.83).  
The mean recurrence rate three month after 
treatment was 31.7% in cimetidine-treated group 
and 30.1% in placebo-treated group, and there 
was no any significant difference between two 
groups(p=0.76). 
This study showed that cimetidine is not more 
effective than placebo in treatment of warts. 
There are a few studies which reported very 
encouraging results about use of cimetidine in 
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warts. In a retrospective assessment of 216 
patients who were administered oral cimetidine 
therapy for verrucae plantaris, it was concluded 
that cimetidine is a safe, effective lone treatment 
modality for verrucae in all age groups.3 
Similarly, Kharfi et al.5 assessed therapeutic 
efficacy of cimetidine in warts in children and 
showed that the cure rate in cimetidine-treated 
group was 60% and in placebo-treated group 
was 33%. All the cases of this study were 
children and it was concluded that cimetidine in 
treatment of children warts is more effective 
than adults.  
However, there are many studies which suggest 
that cimetidine lacks an active role in the 
treatment of warts. A randomized, placebo-
controlled, double-blind study by Yilmaz et al.56 
patients received cimetidine, 25 to 40 mg/kg 
daily, or placebo for 3 months. Patients were 
examined at monthly intervals. At the end of the 
therapy, cure rates obtained were 32% (9 of 28) 
in the cimetidine-treated group and 30.7% (8 of 
26) in the placebo-treated group. No significant 
difference was found between cimetidine and 
placebo in effectiveness.5 
In another study by Glass and Solmon,67 18 adult 
patients were treated with oral cimetidine 
(30mg/kg) for three months, 84% of patients 
cured completely but in this study, there was no 
control group and also the number of patients 
was small. As some of the warts might have 
disappeared themselves, we cannot say that the 
cure rates in these patients is because of 
cimetidine.67 
In a randomized, placebo-controlled, double-
blind study of treating recalcitrant warts in 
adults with a 12 week course of cimetidine at 
2400 mg/day (22-46 mg/kg daily) or placebo, 
the clearance rate of warts with cimetidine and 
placebo was 26% and 5%, respectively (not 
significant; P=0.085).78 
Another double-blind, placebo-controlled study 
compared 12 weeks of treatment with cimetidine 
at 400 mg 3 times per day versus placebo in 
patients over 12-years-old. Wart clearance for 
the cimetidine group was 27% and 22% for 
placebo, which was not a statistically significant 
difference. The study investigators proposed a 
placebo effect for cimetidine.8 
In Tsuyoshi’s study,9 one group was treated with 
15.3 mg/kg cimetidine and the other group was 
treated with 33.2 mg/kg cimetidine for four 
months. In group A, 26.9% were cured 
completely and 15.3% were cured partially. In 
group B, 41.3% were cured completely and 31% 
were cured partially. This study showed that 
high dose of cimetidine had effective role in 
treatment of warts but there was no control 
group and the period of treatment was long.9 
In the study by Karabulut et al.10 one group was 
treated with 15-30 mg/kg cimetidine and the 
other group was treated with placebo for three 
months. Results did not show any significant 
difference between two groups (p=0.21). 
The majority of existing evidence supports our 
results that oral cimetidine has no significant 
therapeutic effect in the treatment of warts. 
Conclusion 
This study showed that cimetidine is not more 
effective than placebo in treatment of warts. 
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